首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

【24h】

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

机译：直接抗病毒药物和HCC早期复发的风险：事不宜迟

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Hepatology: The Journal of the European Association for the Study of the Liver》 |2016年第4期|共2页
作者
Camma Calogero; Cabibbo Giuseppe; Craxi Antonio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing" [J] . Reig Maria, Torres Ferran, Marino Zoe, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2016,第4期

机译：回复“直接抗病毒药物和肝细胞癌（HCC）早期复发的风险：事不宜迟，一事无成”
2. Recurrence of Hepatocellular Carcinoma (HCC) Following Complete Response With Trans Arterial Chemoembolization With Exposure to Direct Acting Antiviral Agents (DAA) [J] . Mavuram Meher Sindhoora, Vasikaran Anush, Pham Ly-Elaine, The American Journal of Gastroenterology . 2018,第Suppla2期

机译：在跨动脉化疗栓塞接触直接作用抗病毒药物（DAA）后复发肝细胞癌（HCC）。
3. Direct Acting Antiviral Therapy is Associated with Shorter Time to HCC Recurrence but not Increased Risk of Recurrence [J] . Singal Amit G., Hoteit Maarouf A., John Binu, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接作用抗病毒治疗与HCC复发的时间较短，但不会增加复发风险
4. THE ROLE OF PERCEIVED RISKS AND RISK PROPENSITY IN SMES' ADOPTION AND CONTINUANCE OF ONLINE DIRECT SALES CHANNELS [C] . Xiaolin Li Annual meeting of the Decision Sciences Institute . 2010

机译：感知风险和风险倾向在接受和继续在线直接销售渠道的过程中的作用
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation [O] . Juliet A. Emamaullee, Mariusz Bral, Glenda Meeberg, 2019

机译：HCV根除与直接作用抗病毒药不会影响肝移植后的候诊肝癌进展或肝癌复发
7. Direct antiviral agents and risk of HCC: Waiting for Godot [O] . Calogero Cammà, Gioacchino Leandro 2018

机译：直接抗病毒药人和HCC的风险：等待戈多特

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号